← Back to Search

Behavioural Intervention

Tobacco Use Disorder in Smokers With and Without Schizophrenia

N/A
Recruiting
Led By Britta Hahn, Ph.D.
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one day (in the ad libitum smoking session), over an 8-hour time frame.
Awards & highlights

Summary

This trial looked at how people with schizophrenia perceive cigarette smoking, and how this affects their smoking habits. The findings suggest that people with schizophrenia perceive smoking differently than the general population, which has implications for how we treat them for smoking cessation.

Eligible Conditions
  • Tobacco Addiction
  • Schizophrenia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one day (in the ad libitum smoking session), over an 8-hour time frame.
This trial's timeline: 3 weeks for screening, Varies for treatment, and one day (in the ad libitum smoking session), over an 8-hour time frame. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in exhaled carbon monoxide
Cigarette Discrimination Accuracy
Secondary outcome measures
Change in the number of research cigarettes smoked
Difference in subjective state composite score

Trial Design

2Treatment groups
Experimental Treatment
Group I: Smokers without schizophreniaExperimental Treatment1 Intervention
This is a diagnostic group (i.e., no diagnosis of schizophrenia), defined independently from this study.
Group II: Smokers with schizophreniaExperimental Treatment1 Intervention
This is a diagnostic group, defined independently from this study.

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor
695 Previous Clinical Trials
376,941 Total Patients Enrolled
Britta Hahn, Ph.D.Principal Investigator - University of Maryland, Baltimore
University of Maryland, Baltimore
3 Previous Clinical Trials
95 Total Patients Enrolled

Media Library

Sampling Research Cigarettes (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04001114 — N/A
Tobacco Addiction Research Study Groups: Smokers without schizophrenia, Smokers with schizophrenia
Tobacco Addiction Clinical Trial 2023: Sampling Research Cigarettes Highlights & Side Effects. Trial Name: NCT04001114 — N/A
Sampling Research Cigarettes (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04001114 — N/A
~22 spots leftby Jul 2025